全文获取类型
收费全文 | 7258篇 |
免费 | 361篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 100篇 |
儿科学 | 166篇 |
妇产科学 | 26篇 |
基础医学 | 773篇 |
口腔科学 | 192篇 |
临床医学 | 474篇 |
内科学 | 1986篇 |
皮肤病学 | 166篇 |
神经病学 | 415篇 |
特种医学 | 270篇 |
外科学 | 1156篇 |
综合类 | 31篇 |
预防医学 | 203篇 |
眼科学 | 256篇 |
药学 | 633篇 |
中国医学 | 9篇 |
肿瘤学 | 834篇 |
出版年
2024年 | 14篇 |
2023年 | 51篇 |
2022年 | 122篇 |
2021年 | 209篇 |
2020年 | 128篇 |
2019年 | 155篇 |
2018年 | 211篇 |
2017年 | 152篇 |
2016年 | 190篇 |
2015年 | 203篇 |
2014年 | 239篇 |
2013年 | 294篇 |
2012年 | 514篇 |
2011年 | 541篇 |
2010年 | 330篇 |
2009年 | 254篇 |
2008年 | 484篇 |
2007年 | 493篇 |
2006年 | 490篇 |
2005年 | 458篇 |
2004年 | 424篇 |
2003年 | 389篇 |
2002年 | 385篇 |
2001年 | 71篇 |
2000年 | 64篇 |
1999年 | 93篇 |
1998年 | 77篇 |
1997年 | 67篇 |
1996年 | 69篇 |
1995年 | 56篇 |
1994年 | 47篇 |
1993年 | 38篇 |
1992年 | 40篇 |
1991年 | 31篇 |
1990年 | 30篇 |
1989年 | 41篇 |
1988年 | 26篇 |
1987年 | 25篇 |
1986年 | 14篇 |
1985年 | 29篇 |
1984年 | 24篇 |
1983年 | 11篇 |
1982年 | 15篇 |
1981年 | 19篇 |
1980年 | 12篇 |
1979年 | 15篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 6篇 |
排序方式: 共有7690条查询结果,搜索用时 0 毫秒
101.
Lichen amyloidosus associated with Kimura's disease: successful treatment with cyclosporine 总被引:3,自引:0,他引:3
We describe here a case of a 33-year-old man who had lichen amyloidosus associated with Kimura's disease. In this case, treatment with cyclosporine dramatically improved the lesions of both Kimura's disease and lichen amyloidosus. Although Kimura's disease and lichen amyloidosus are both rare distinct entities, to our knowledge, 11 cases of association of Kimura's disease and lichen amyloidosus have been described previously. 相似文献
102.
103.
Akira Shimizu Atsuyoshi Mita Kazuki Yoshizawa Yasunari Ohno Yuichi Masuda Yuji Soejima 《Hepatobiliary & pancreatic diseases international : HBPD INT》2020,19(4):334-341
BackgroundSince the first success in an adult patient, living donor liver transplantation (LDLT) has become an universally used procedure. Small-for-size syndrome (SFSS) is a well-known complication after partial LT, especially in cases of adult-to-adult LDLT. The definition of SFSS slightly varies among transplant physicians. The use of a partial liver graft has risks of SFSS development. Persistent portal vein (PV) hypertension and PV hyper-perfusion after LT were identified as the main factors. Hence, various approaches were explored to modulate PV flow and decrease PV pressure in order to alleviate this syndrome. Herein, the definition, clinical symptoms, pathophysiology, basic research, as well as preventive and treatment strategies for SFSS are reviewed based on an extensive review of the literature and on our own experiences.Data sourcesThe articles were collected through PubMed using search terms “liver transplantation”, “living donor liver transplantation”, “living liver donation”, “partial graft”, “small-for-size graft”, “small-for-size syndrome”, “graft volume”, “remnant liver”, “standard liver volume”, “graft to recipient body weight ratio”, “sarcopenia”, “porcine”, “swine”, and “rat”. English publications published before March 31, 2020 were included in this review.ResultsMany transplant surgeons performed PV flow modulation, including portocaval shunt, splenic artery ligation and splenectomy. With these techniques, patient outcome has been improved even when using a \"small\" graft. Other factors, such as preoperative recipients’ nutritional and skeletal muscle status, graft congestion, and donor factors, were also identified as risk factors which all have been addressed using various strategies.ConclusionsThe surgical approach controlling PV flow and pressure could help to prevent SFSS especially in severely ill recipients. In the absence of efficacious medications to resolve SFSS, conservative treatments, including aggressive fluid balance correction for massive ascites, anti-microbiological therapy to prevent or control sepsis and intensive nutritional therapy, are all required if SFSS could not be prevented. 相似文献
104.
Eiji Wada Mitsuru Fukui Kazuhisa Takahashi Daisaku Takeuchi Hiroshi Hashizume Masahiko Kanamori Noboru Hosono Tsukasa Kanchiku Yuichi Kasai Miho Sekiguchi Shin-ichi Konno Mamoru Kawakami Kazuo Yonenobu 《Journal of orthopaedic science》2019,24(1):57-61
Background
In 1999, the Japanese Orthopaedic Association decided to develop a new Cervical Myelopathy Evaluation Questionnaire (JOACMEQ). The final version of the JOACMEQ, comprising 24 questions and five domains (cervical spine function (CF); upper extremity function (UF); lower extremity function (LF); bladder function (BF); and quality of life (QOL)), was established after three nationwide investigations. The fourth investigation, reported in this paper, was performed to confirm the responsiveness of the questionnaire.Methods
A total of 137 patients with cervical myelopathy were included in the study. Each patient was interviewed twice using the JOACMEQ before and after treatment. At the second interview, the patients self-rated their condition in five domains for “worse,” “somewhat worse,” “no change,” “somewhat better,” or “better,” and these scores were defined as the external assessment rating. The difference of the points in five domains between the first and the second interview was calculated against each external assessment. Based on the results, substantial clinical benefit (SCB) thresholds for the JOACMEQ were determined.Results
The statistically significant median values of the acquired points were 17.5 for CF, 16.0 and 21.0 for UF, 27.0 and 20.5 for LF, 13.0 for BF, and 29.0 for QOL. After consideration of the results, the committee decided that an acquired point ≥20 could be interpreted as representing an SCB threshold for the JOACMEQ.Conclusion
We have concluded that a treatment can be judged to be effective for a patient if 1) The patient give all answers for the questions necessary to calculate the functional score of a domain and an increase of ≥20 points is obtained for that score, or 2) The functional score after treatment is > 90 points even if the answer for the unanswered questions was supposed to be the worst possible choice. 相似文献105.
Yoshinaga M Anan R Nomura Y Tanaka Y Tanaka Y Sarantuya J Oku S Nishi S Kawano Y Tei C Arima K 《The American journal of cardiology》2004,94(9):1186-1189
The prevalence of Brugada's electrocardiographic (ECG) pattern in 7,022 male adolescents in the seventh grade was determined, and the same subjects were reexamined 3 years later, while in tenth grade. Two subjects (0.03%) and 7 subjects (0.10%) showed Brugada's ECG pattern by the conventional criterion (J point or ST-segment >/=0.1 mV in leads V(1) to V(3)), and no subjects (0%) and 2 subjects (0.03%) fulfilled the recent criterion (J point or ST-segment >/=0.2 mV) in the seventh and tenth grades, respectively, indicating that Brugada's ECG pattern begins to appear during junior high school and increases until late adulthood. 相似文献
106.
Kensuke Suenaga M.D. Yuichi Yokoyama M.D. kazuichi Okazaki M.D. Yasutake Yamamoto M.D. 《The American journal of gastroenterology》1995,90(1):76-80
Objectives : It is still controversial whether or not a mycobacterial infection may be a cause of Crohn's disease. Mycobaclerium paratuberculosis may be very difficult to detect using routine culture techniques. To clarify this, we delected mycobacterial DNA in patients with inflammatory bowel disease. Methods : IS900 sequences highly specific to M. paratuberculosis and groEL gene encoding a conserved mycobacterial antigen were studied in colonic mucosa using polymerase chain reaction (PCR). PCR products were analyzed by Southern blot hybridization. Results : IS900 sequences were detected in all (100%)of 10 patients with Crohan's disease, in 11 (61.1%) of 18 patients with ulcerative colitis, and in 14 (87.5%) of 16 control patients with noninflammatory bowel disease. All IS900 positive samples had groEL PCR products. Conclusions : Our results, on the basis of the prevalence, do not support the hypothesis that M. paratuberculosis is involved in the pathogenesis of Crohn's disease. 相似文献
107.
108.
Takahashi H Takeishi Y Seidler T Arimoto T Akiyama H Hozumi Y Koyama Y Shishido T Tsunoda Y Niizeki T Nozaki N Abe J Hasenfuss G Goto K Kubota I 《Circulation》2005,111(12):1510-1516
109.
Objectives
Since the Cabinet’s decision concerning the Basic Policies 2005, the Japanese government has implemented specific measures to suppress increases in national medical care expenditure. However, we believe that the economic significance of medical care should be quantified in terms of its economic impact on national medical care expenditure. No one has examined the economic impact of all medical institutions in Japan using data from a statement of profits and losses. We used an input–output analysis to quantitatively estimate economic impact of medical care and examined its estimation range with a probabilistic sensitivity analysis.Methods
To estimate the economic impact and economic impact multipliers of all medical institutions in Japan, an input–output analysis model was developed using an input–output table, statement of profits and losses, margin rates, employee income rates, consumption propensity and an equilibrium output model. Probabilistic sensitivity analysis was conducted using a Monte Carlo simulation.Results
Economic impact of medical care in all medical institutions was ¥72,107.4 billion ($661.5 billion). This impact yielded a 2.78-fold return of medical care expenditure with a 95 % confidence interval ranging from 2.74 to 2.90.Conclusion
Economic impact of medical care in Japan was two to three times the medical care expenditure (per unit). Production inducement of medical care is comparable to other industrial sectors that are highly influential toward the economy. The contribution to medical care should be evaluated more explicitly in national medical care expenditure policies. 相似文献110.
Yamasaki Yuichi Kubota Tomohiro Takei Syuji Imanaka Hiroyuki Nonaka Yukiko Kawano Yoshifumi 《Clinical rheumatology》2021,40(1):393-397
Clinical Rheumatology - Cryopyrin-associated periodic fever syndrome (CAPS) is a highly debilitating disorder, which is characterized by unregulated interleukin-1β production driven by... 相似文献